Oria Bioscience

Oria Bioscience is a pioneering French TechBio company expert in generating organelles. We deliver high-quality, intact living organelles, surrounded by their therapeutic membrane targets. For the first time, organelles are being distributed globally and are fully compatible with high-throughput screening campaigns and drug development efforts. Thanks to our microfluidics technology, we supply pharmaceutical laboratories and CROs with purified organelles (lysosomes, mitochondria, and endoplasmic reticulum). Working directly with organelles improves efficacy results, reduces attrition rates in clinical phases, accelerates Hit-to-Lead and Lead Optimization phases, and minimizes your carbon footprint by reducing resources used. Oria’s team brings together over 50 years of expertise in organelles and microfluidics, dedicated to delivering organelles worldwide to meet drug discovery needs. We are making organelles as accessible as cells, driving innovation across all health sectors.